66 related articles for article (PubMed ID: 11428597)
1. Influence of cytoimmunological state on the development of tuberculosis in heart transplant recipients.
Hirata N; Koerner MM; Tenderich G; Minami K; Mannebach H; Kleesiek K; Koerfer R
Surg Today; 2001; 31(6):482-6. PubMed ID: 11428597
[TBL] [Abstract][Full Text] [Related]
2. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis in heart transplant recipients.
Körner MM; Hirata N; Tenderich G; Minami K; Mannebach H; Kleesiek K; Körfer R
Chest; 1997 Feb; 111(2):365-9. PubMed ID: 9041983
[TBL] [Abstract][Full Text] [Related]
4. Heart transplantation: 25 years' single-centre experience.
Bruschi G; Colombo T; Oliva F; Botta L; Morici N; Cannata A; Vittori C; Turazza F; Garascia A; Pedrazzini G; Frigerio M; Martinelli L
J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):637-47. PubMed ID: 23340045
[TBL] [Abstract][Full Text] [Related]
5. A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.
Chen CH; Shu KH; Ho HC; Cheng SB; Lin CC; Wei HJ; Lin CH; Chang SN; Wu MJ
Transplant Proc; 2014 May; 46(4):1032-5. PubMed ID: 24815120
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of functionally distinct T-lymphocyte subsets in heart transplant recipients after induction therapy with anti-CD25 monoclonal antibodies.
Lanio N; Sarmiento E; Gallego A; Navarro J; Palomo J; Fernandez-Yañez J; Ruiz M; Fernandez-Cruz E; Carbone J
Transpl Immunol; 2013 Jun; 28(4):176-82. PubMed ID: 23611763
[TBL] [Abstract][Full Text] [Related]
8. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
9. Utility of immune monitoring in heart transplant recipients on everolimus-based immune suppression.
Ben Gal T; Israeli M; Yaari V; Hasdai D; Matz I; Yussim A; Battler A; Klein T; Medalion B
Clin Transplant; 2014 Apr; 28(4):428-33. PubMed ID: 24649896
[TBL] [Abstract][Full Text] [Related]
10. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting 10-year survival after heart transplantation.
Radovancevic B; Konuralp C; Vrtovec B; Radovancevic R; Thomas CD; Zaqqa M; Vaughn WK; Frazier OH
J Heart Lung Transplant; 2005 Feb; 24(2):156-9. PubMed ID: 15701430
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
13. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
Kobashigawa J; David K; Morris J; Chu AH; Steffen BJ; Gotz VP; Gordon RD
Transplant Proc; 2005 Mar; 37(2):1333-9. PubMed ID: 15848713
[TBL] [Abstract][Full Text] [Related]
14. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
[TBL] [Abstract][Full Text] [Related]
15. Cytoimmunological monitoring in acute rejection and viral, bacterial or fungal infection following transplantation.
Ertel W; Reichenspurner H; Lersch C; Hammer C; Plahl M; Lehmann M; Kemkes BM; Osterholzer G; Reble B; Reichart B
J Heart Transplant; 1985; 4(4):390-4. PubMed ID: 3916512
[TBL] [Abstract][Full Text] [Related]
16. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
[TBL] [Abstract][Full Text] [Related]
17. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
[TBL] [Abstract][Full Text] [Related]
19. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
20. Heart transplantation in females: the experience in Puerto Rico.
Banchs HL; González V; González Cancel I; Quintana C; Calderón R; Altieri PI
Bol Asoc Med P R; 2005; 97(4):248-56. PubMed ID: 16599066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
